NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yet gentle and non-perturbative manner. Cargo delivery via NanoStraws will drastically reduce the working steps, costs and technical difficulties involved in cell therapy manufacturing. By overcoming viability and manufacturing challenges plaguing traditional viral-based development, NAVAN is actively pursuing innovative therapies in a broad range of indications via strategic collaboration with numerous biopharma companies.
NAVAN is a resident company at JLABS @ SSF located at Oyster Point in South San Francisco, CA, and is supported by the National Science Foundationᅢᄁ¬ツᆲ¬トᄁs Small Business Technology Transfer Program Phase II (award no. 1759075). For more information on NAVAN, please visit www.navanbio.com.